What the six lenses say about AKUMS — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How AKUMS’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | -1.0pp | -1.6pp | +17.4pp | +35.5pp | +61.8pp | +65.9pp |
Nifty 500 Broad-market baseline | -1.0pp | -1.6pp | +16.3pp | +33.9pp | +56.1pp | +60.7pp |
Sector Own-sector index | — | — | +13.5pp | +27.9pp | +43.0pp | +39.9pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
AKUMS daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
AKUMS ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 1,019 | 1,033 | 1,010 | 1,056 | 1,024 | 1,018 | 1,160 | 1,158 |
| ↳ change QoQ | — | +1.4% | -2.2% | +4.5% | -3.0% | -0.6% | +13.9% | -0.2% |
| EBITDA (₹cr) | 135 | 138 | 141 | 94 | 129 | 94 | 147 | 152 |
| EBITDA margin | 13.2% | 13.4% | 13.9% | 8.9% | 12.6% | 9.2% | 12.7% | 13.1% |
| PAT (₹cr) | 61 | 67 | 66 | 150 | 65 | 43 | 68 | 81 |
| ↳ change QoQ | — | +8.9% | -0.5% | +126.2% | -56.7% | -33.8% | +58.1% | +19.1% |
| Net margin | 6.0% | 6.5% | 6.6% | 14.2% | 6.3% | 4.2% | 5.9% | 7.0% |
| EPS (₹) | 4.21 | 4.37 | 4.26 | 9.38 | 4.03 | 2.59 | 4.21 | 5.38 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding AKUMS (7)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Franklin India Small Cap Gr | 0.96% | 14,467 | |
| Nippon India Pharma Gr | 1.00% | 9,279 | |
| Nippon India Pharma Bns | 1.00% | 9,279 | |
| ICICI Pru Pharma Healthcare Diag Gr | 1.89% | 6,803 | |
| Franklin India Multi Cap Reg Gr | 1.35% | 5,096 | |
| Old Bridge Flexi Cap Reg Gr | 2.39% | 256 | |
| Samco Multi Cap Reg Gr | 0.60% | 228 |
ETFs holding AKUMS (0)
No tracked ETF holds AKUMS ≥0.5%.